Literature DB >> 3702282

Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosuppression.

G A Müller, L Seipel, T Risler.   

Abstract

A retrospective study was conducted to evaluate the efficacy of plasmapheresis in combination with different immunosuppressive drugs ("pulse" therapy, azathioprine or cyclophosphamide together with steroids) in nine patients presenting with rapidly progressive glomerulonephritis (RPGN) not mediated by antibody to glomerular basement membrane. Six of these patients had to be initially dialysed. All patients underwent renal biopsy, which revealed that seven patients had a minimum of 80% crescents and five had interstitial fibrosis. Recovery of renal function was observed in seven patients (78%). All patients without interstitial fibrosis were recompensated for at least 14 months after the acute onset of RPGN. Those who presented with interstitial fibrosis declined to endstage renal failure after 13 months requiring chronic hemodialysis treatment or cadaveric kidney transplantation. On the basis of these findings interstitial fibrosis seems to be a limiting factor for the prognosis of non-anti-GBM-antibody mediated RPGN.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702282     DOI: 10.1007/bf01711654

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  27 in total

Review 1.  Crescenteric glomerulonephritis: occurrence, mechanisms, and prognosis.

Authors:  S Rosen
Journal:  Pathol Annu       Date:  1975

2.  The differential diagnosis of crescentic glomerulonephritis. The pathology of specific lesions with prognostic implications.

Authors:  B H Spargo; N G Ordóñez; J C Ringus
Journal:  Hum Pathol       Date:  1977-03       Impact factor: 3.466

3.  [Nephrotic syndrome of the adult. 1].

Authors:  H Sarre; R Kluthe; H J Jesdinsky; P Baum; E Buchborn; F Dürr; H Edel; K W Fritz; A Heidland; R Heintz; G A Jutzler; P Körtge; H J Krecke; W Lange; H Nieth; J Oberwittler; D Oechslen; P Portwich; J Schirmeister; W Schoeppe; G Schütterle; H G Sieberth; E Wetzels
Journal:  Dtsch Med Wochenschr       Date:  1971-02-05       Impact factor: 0.628

4.  Glomerulonephritis: current problems and understanding.

Authors:  J S Cameron
Journal:  J Lab Clin Med       Date:  1982-06

5.  Immunosuppression and plasma-exchange in the treatment of Goodpasture's syndrome.

Authors:  C M Lockwood; A J Rees; T A Pearson; D J Evans; D K Peters; C B Wilson
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

6.  The macrophagen in human rapidly progressive glomerulonephritis.

Authors:  R C Atkins; S R Holdsworth; E F Glasgow; F E Matthews
Journal:  Lancet       Date:  1976-04-17       Impact factor: 79.321

7.  Autoregulation of autoantibody synthesis in mercuric chloride nephritis in the Brown Norway rat. II. Presence of antigen-augmentable plaque-forming cells in the spleen is associated with humoral factors behaving as auto-anti-idiotypic antibodies.

Authors:  J M Chalopin; C M Lockwood
Journal:  Eur J Immunol       Date:  1984-05       Impact factor: 5.532

8.  The origin of glomerular crescents in experimental nephrotoxic serum nephritis in the rabbit.

Authors:  V Cattell; S W Jamieson
Journal:  Lab Invest       Date:  1978-12       Impact factor: 5.662

9.  Immune complexes and reticuloendothelial system function in human disease.

Authors:  T J Lawley
Journal:  J Invest Dermatol       Date:  1980-05       Impact factor: 8.551

10.  The therapy of rapidly progressive glomerulonephritis.

Authors:  H G Sieberth; N Maurin
Journal:  Klin Wochenschr       Date:  1983-10-17
View more
  4 in total

1.  Long-term clinical course in acute crescentic glomerulonephritis.

Authors:  D Bach; K Hauser; B Grabensee
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

2.  [Phenotypic heterogeneity of cardiac myxomas].

Authors:  G A Müller; T Klyscz; J Markovic-Lipkovski; L Seipel; H D Waller
Journal:  Klin Wochenschr       Date:  1987-10-01

3.  Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation.

Authors:  C A Müller; H Hebart; A Roos; H Roos; M Steidle; H Einsele
Journal:  Med Microbiol Immunol       Date:  1995-10       Impact factor: 3.402

4.  Cytomegalovirus in liver biopsies of marrow transplant recipients: detection methods, clinical, histological and immunohistological features.

Authors:  H Einsele; H D Waller; P Weber; N Frickhofen; S Dette; H P Horny; A Roos; H Roos; H Hebart; H Schmidt
Journal:  Med Microbiol Immunol       Date:  1994-09       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.